Methods for treating renal cell carcinoma
US8012465B2 · kind B2 · utility
40Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2009 |
| Grant date | Sep 6, 2011 |
| Priority date | — |
| Expiry date | Jul 28, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating renal cell carcinoma using low doses of IL-2 are disclosed. In particular, the invention relates to methods of treating metastatic renal cell carcinoma in patients who are renally impaired and/or intolerant of high dose IL-2 therapy. The therapeutic regimen described herein significantly inhibits tumor growth with reduced toxicity and adverse side effects compared to high dose IL-2 therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.